To join or not to join a gym: That is the question. If you opt out of building a home gym, you can join a club and have access to more weights and machines. Friends and classes motivate you to keep ...

Ocular Therapeutix (OCUL) is a Strong Buy, driven by the pivotal SOL-1 Phase 3 trial for AXPAXLI™ in wet AMD, with topline results expected Q1 2026. AXPAXLI™ leverages proven science and a de-risked ...

Prince Andrew has announced he will no longer use his title of Duke of York and several royal honours, following ongoing scrutiny of his ties to Jeffrey Epstein and renewed public pressure. Although ...

Oct 10 (Reuters) - Drugmaker Bristol Myers Squibb (BMY.N), opens new tab said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5 billion in cash, aiming to ...

Drugmaker Bristol-Myers Squibb said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5 billion in cash, aiming to diversify from legacy products facing ...

Orbital Therapeutics is currently running IND-enabling studies for its lead candidate. (iStock / Getty Images Plus) The stars have aligned for Bristol Myers Squibb and Orbital Therapeutics. Pushing ...

Bristol Myers Squibb has agreed to buy privately held biotechnology company Orbital Therapeutics for $1.5 billion in cash in a deal that bolsters the drugmaker's cell-therapy portfolio. Bristol Myers ...

As I’ve said before, passwords suck. Microsoft agrees—last year, it announced a goal of getting one billion users to embrace passkeys instead. As part of that effort, setting up a passkey for a ...

Setting up your iPhone for the first time is an essential process that ensures your device is ready for secure and efficient use. This guide provides a detailed, step-by-step walkthrough, covering ...

IoCDB Share project repository, a CTI platform that collects data from VirusTotal, AlienVault OTX, PolySwarm and AbuseIPDB APIs for hashes, domains and IPs. AegisFlow is a threat-aware CI/CD pipeline ...